INM

InMed Pharmaceuticals Inc.

0.24 USD
-0.00 (-1.80%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

InMed Pharmaceuticals Inc. stock is down -12.96% since 30 days ago. The next earnings date is Sep 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.36% of the previous 10 June’s closed higher than May.

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. researches and develops cannabinoid-based therapies. Lead product INM-755, a cannabinoidol topical cream, is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing InM-088, which is in preclinical studies for the. treatment of glaucoma and pain.